Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
17-20 March, 2025
Pharmagora Plus 2025Pharmagora Plus 2025
Not Confirmed
Not Confirmed
08-09 March, 2025
Organic Process R&DOrganic Process R&D
Not Confirmed
Not Confirmed
10-12 March, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
17-20 March, 2025
Pharmagora Plus 2025Pharmagora Plus 2025
Industry Trade Show
Not Confirmed
08-09 March, 2025
Organic Process R&DOrganic Process R&D
Industry Trade Show
Not Confirmed
10-12 March, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/ai-drug-discovery-market-to-grow-30-cagr-to-reach-us-35-bn-by-2034-novo-lilly-bms-forge-deals
19 Jan 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/index-pharmaceuticals-announces-expected-cash-balance-per-march-31-2024-302039363.html
22 Nov 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/index-pharmaceuticals-discontinues-cobitolimod-phase-iii-program-301995261.html
20 Oct 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/index-pharmaceuticals-has-been-granted-a-new-patent-for-cobitolimod-in-south-korea-301963166.html
https://www.prnewswire.com/news-releases/index-pharmaceuticals-announces-that-all-patients-needed-for-the-cobitolimod-dose-selection-milestone-have-completed-induction-study-1-of-the-phase-iii-program-conclude-301953209.html
05 Oct 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/index-pharmaceuticals-is-attending-the-uegw-2023-congress-301948229.html
22 Aug 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/positive-results-from-pk-study-with-cobitolimod-selected-as-one-of-the-best-abstracts-for-poster-presentation-at-uegw-index-pharmaceuticals-301906507.html
ABOUT THIS PAGE